Maarten van Eijk
5PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 07, 2022
Development of a population pharmacokinetic/pharmacodynamic model for various oral paclitaxel formulations co-administered with ritonavir and thrombospondin-1 based on data from early phase clinical studies.Maarten van Eijk, Huixin Yu, Emilia Sawicki
|Jan 26, 2022
The influence of docetaxel schedule on treatment tolerability and efficacy in patients with metastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.Maarten van Eijk, Marit A C Vermunt, Erik van Werkhoven
|Mar 12, 2021
ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration-resistant prostate cancer patients: A phase Ib study.Marit A C Vermunt, Debbie G J Robbrecht, Lot A Devriese
|Mar 02, 2021
Investigating the influence of relevant pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of orally administered docetaxel combined with ritonavir.Maarten van Eijk, Dick Pluim, Thomas P C Dorlo
|Jul 17, 2019
Cytochrome P450 3A4, 3A5, and 2C8 expression in breast, prostate, lung, endometrial, and ovarian tumors: relevance for resistance to taxanes.Maarten van Eijk, René J Boosman, Alfred H Schinkel
Pageof 1
